Gene: TM7SF3
Official Full Name: transmembrane 7 superfamily member 3provided by HGNC
Gene Summary: Involved in cellular response to unfolded protein; negative regulation of programmed cell death; and positive regulation of insulin secretion. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22208 | TM7SF3 Knockout cell line (HeLa) | Human | TM7SF3 | 1:3~1:6 | Negative | Online Inquiry |
KO22209 | TM7SF3 Knockout cell line (HCT 116) | Human | TM7SF3 | 1:2~1:4 | Negative | Online Inquiry |
KO22210 | TM7SF3 Knockout cell line (HEK293) | Human | TM7SF3 | 1:3~1:6 | Negative | Online Inquiry |
KO22211 | TM7SF3 Knockout cell line (A549) | Human | TM7SF3 | 1:3~1:4 | Negative | Online Inquiry |
TM7SF3 Gene Knockout Cell Lines are engineered cellular models precisely designed to study the functional implications of the TM7SF3 gene, which is implicated in various biological processes and disease states. These cell lines utilize CRISPR-Cas9 technology to achieve site-specific disruptions in the TM7SF3 gene, resulting in a robust model for investigating gene function and protein interactions.
The key mechanism by which these knockout cell lines operate hinges on the targeted deletion of the TM7SF3 coding sequence, allowing researchers to delineate downstream effects on cellular pathways. By observing phenotypic changes such as alterations in proliferation, differentiation, and apoptosis, scientists can gain insights into the biological roles of TM7SF3. Moreover, these cell lines facilitate the examination of the gene's implications in disease mechanisms, particularly in cancer and immune responses, thereby serving as critical tools in the context of translational research.
In a clinical or research setting, TM7SF3 Gene Knockout Cell Lines offer significant advantages over traditional methods, which may rely on less specific gene silencing approaches or less stable knockdown models. Their inherent reliability ensures consistent experimental results, enabling researchers to draw more accurate conclusions. Furthermore, these cell lines are compatible with high-throughput screening applications, making them ideal for drug discovery and therapeutic development.
Researchers and clinicians will find substantial value in utilizing TM7SF3 Gene Knockout Cell Lines due to their ability to provide precise insights into gene function that are essential for advancing personalized medicine initiatives. By understanding the role of TM7SF3, target users can contribute to the identification of novel biomarkers or therapeutic targets, ultimately enhancing patient care.
Our company is dedicated to advancing biological research and innovation, offering a range of high-quality products such as TM7SF3 Gene Knockout Cell Lines that are backed by rigorous quality control and a deep commitment to customer support.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.